MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
58.18
+2.19
+3.91%
Pre Market: 58.39 +0.21 +0.36% 05:54 12/05 EST
OPEN
55.99
PREV CLOSE
55.99
HIGH
59.77
LOW
54.93
VOLUME
249
TURNOVER
271.37M
52 WEEK HIGH
78.48
52 WEEK LOW
30.04
MARKET CAP
5.54B
P/E (TTM)
-10.4265
1D
5D
1M
3M
1Y
5Y
1D
Cathie Wood's Buys And Rumors Aside, Here's Why Crispr Therapeutics Is A Strong Buy
Seeking Alpha · 19h ago
Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?
NASDAQ · 1d ago
CRISPR Therapeutics: CTX310 De-Risks, CASGEVY Disappoints Amid Takeover Rumors
Seeking Alpha · 2d ago
Bernstein Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP)
TipRanks · 2d ago
ARKB, HOOD, SHOP, WRD: Cathie Wood Expands Crypto and AI Bets, Trims Stakes in Roku and GitLab Stocks
TipRanks · 3d ago
Crispr Therapeutics pares loss amid takeover speculation
Seeking Alpha · 3d ago
Crispr Therapeutics rumor highlighted in Betaville blog
TipRanks · 3d ago
Cathie Wood's Ark Invest weekly recap: Boosts AI and Crypto Bets, Trims Palantir, GitLab, and AMD
Seeking Alpha · 3d ago
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.